APA (7th ed.) Citation

S, T., L, I., M, H., W, F., K, M., S, N., . . . K, F. (2026). Comparative efficacy of immune checkpoint inhibitor combination therapies by metastatic site in metastatic renal cell carcinoma. Scientific reports, 16(1), 3303. https://doi.org/10.1038/s41598-025-33198-x

Chicago Style (17th ed.) Citation

S, Toyoda, et al. "Comparative Efficacy of Immune Checkpoint Inhibitor Combination Therapies by Metastatic Site in Metastatic Renal Cell Carcinoma." Scientific Reports 16, no. 1 (2026): 3303. https://doi.org/10.1038/s41598-025-33198-x.

MLA (9th ed.) Citation

S, Toyoda, et al. "Comparative Efficacy of Immune Checkpoint Inhibitor Combination Therapies by Metastatic Site in Metastatic Renal Cell Carcinoma." Scientific Reports, vol. 16, no. 1, 2026, p. 3303, https://doi.org/10.1038/s41598-025-33198-x.